Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...

The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035[1], driven by a fundamental shift in cancer treatment philosophy. Biomarker-guided therapy ...

The NHS has an extraordinary opportunity in 2026. Unified data, decision intelligence, and strong workforce capability can ...

Following its successful listing on the Main Board of the Hong Kong Stock Exchange (02665.HK), Seyond, a global leader in image-grade LiDAR solutions, is entering a new phase of growth marked by ...

Here is a summary of the eight scenarios in Saxo’s Outrageous Predictions 2026 and the market angles to watch. The first and ...

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

What makes 2025 distinct is the speed and scale at which some of the startup controversies unfolded, triggering consequences ...

The invention makes bold yet practical claims, offering reliable predictions of multiple material properties with built-in ...

Irish fashion design graduates are undereducated about how to protect their work from being copied by fast fashion retailers.

HRS Aluglaze IPO subscription status: After the end of the day bidding, the SME IPO was subscribed to nearly 42 times.(An AI-generated image) HRS Aluglaze IPO: Following the end of bidding on 16 ...